🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-12-31
Trial ID
NCT04194671
Treatments Being Tested
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
Patients enrolled on this study will have received a stem cell transplant. ...
Status
Withdrawn
Location
Texas Childrens Hospital
Start Date
2018-03-01
Trial ID
NCT02313844
Treatments Being Tested
The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-03-21
Trial ID
NCT05015426
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and prel...
Status
Unknown
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2021-04-26
Trial ID
NCT04590118
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
A3D is a phase I/II clinical trial. The primary objective is to evaluate th...
Status
Recruiting
Location
University Hospital of Toulouse
Start Date
2026-05-07
Trial ID
NCT07367815
In our prior study on the therapeutic mechanism of UCB, changes in cytokine...
Status
Completed
Location
CHA Bundang Medical Center
Start Date
2015-07-29
Trial ID
NCT03130816
Treatments Being Tested